Researchers Decry Cutbacks In Government Grant Support

Many fear that the 1993 NIH allocation is likely to curtail-- if not wipe out altogether--some current and envisioned projects Date: April 27, 1992 WASHINGTON--Scientists in the United States research community are distraught over the president's 1993 budget for the National Institutes of Health, put before Congress last month. Specifically, they are troubled by funding adjustments that trim basic research grants to below what they consider adequate amounts to support their investigations. Ad

Written byBradie Metheny
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Many fear that the 1993 NIH allocation is likely to curtail-- if not wipe out altogether--some current and envisioned projects
Date: April 27, 1992

WASHINGTON--Scientists in the United States research community are distraught over the president's 1993 budget for the National Institutes of Health, put before Congress last month.

Specifically, they are troubled by funding adjustments that trim basic research grants to below what they consider adequate amounts to support their investigations. Adding to their displeasure is an expected decrease in the number of new individual investigator-initiated grants to be awarded and the reduced chances they will have of being funded at all by NIH in fiscal year 1993.

"These budgetary adjustments are just another reminder that science is under siege. And, for the first time in 33 years, 30 states have reduced their support for public higher education. These are both chilling messages to the bench scientist," contends John ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies